The PeptideChat Blog

The GLOW stack pairs three repair-associated peptides. Here is the reasoning behind each one, the evidence for each on its own, and why the trio itself has never been tested.

Why a GHRH analog is paired with a ghrelin mimetic, what the human studies of CJC-1295 and ipamorelin each showed, and why the pair itself has never been tested in a trial.

Approved drug, compounded medication, or research-use-only chemical: how manufacturing standards, sterility and oversight differ, and what a certificate of analysis can and cannot prove.

From semaglutide and tirzepatide to AOD-9604 and tesofensine: the strongest published evidence for each compound linked to weight loss, with trial numbers and clear caveats.

DSIP, GHRH, ghrelin, orexin-A, epitalon and more: what sleep research exists for each, why most of it is small and decades old, and how melatonin compares.

GHK-Cu, Matrixyl, Argireline, glutathione and more: the strongest evidence for each skin peptide, and why many cosmetic studies are small, industry-run or test blends.

BPC-157, TB-500, GHK-Cu, LL-37, KPV and MGF are often linked to healing. Here is the strongest evidence for each, and how little of it comes from people.

A plain-language guide to Semax, Selank, their N-acetyl variants, Dihexa, Cerebrolysin and P21: what each is, how strong the evidence is, and where the data run out.

What the pharmaceutical literature says about how peptides break down, why freeze-dried powder is more stable than solution, and why data for specific research peptides is scarce.

How tesamorelin works, what its phase 3 trials found for visceral fat in HIV, what is known outside that use, the side effects reported, and how it differs from sermorelin and CJC-1295.

MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA. Here is what mouse studies found, what human blood-level studies show, and why there are no human treatment trials yet.

Where GHK-Cu comes from, what wound-healing and skin studies found, why its gene-expression claims need context, and the large gap between topical and injectable evidence.

What half-life means, why natural peptides are cleared within minutes, and how albumin binding, DAC, PEGylation and amino-acid swaps stretch that to days, with sourced numbers.

Why most peptides are broken down or blocked in the gut, how oral semaglutide gets around it, and what the evidence says about oral BPC-157, nasal sprays and peptide creams.

A tour of PeptideChat's newest tools: the reconstitution calculator, a 55-term glossary, 17 side-by-side comparisons, a redesigned My Schedule, and why each one exists.

Why a unit on a U-100 insulin syringe is a volume, not a dose: how units, millilitres and micrograms relate, what barrel sizes mean, and how water volume changes the count.

What reconstitution means, why peptides ship as freeze-dried powder, bacteriostatic vs sterile water, and the concentration math behind U-100 units, with worked examples.

Cells, animals, or people? Placebo or no placebo? Learn the questions that separate strong peptide evidence from weak, and how to check any claim yourself on PubMed.

Nausea, gallbladder risk, the pancreatitis question, lean mass loss and weight regain after stopping, told only with numbers from the STEP and SURMOUNT trials and meta-analyses.

What endotoxin is, why it matters in anything injected, how LAL testing works, and why a sterile vial with a 99% HPLC purity number can still be a problem.

A 2026 investigation found GLP-3 R sold over the counter in Brooklyn bodegas, a 265% jump in poison-center calls, and a lab certificate that appeared to describe a different peptide than the one on the label. Here's what that teaches about reading a COA.

On July 23-24, 2026, an FDA advisory committee voted to recommend six of seven peptides for legal compounding — over the objections of the FDA's own reviewers. Nothing has legally changed yet, and the details matter more than the headlines.

Cagrilintide, zenagamtide and petrelintide made this June's diabetes meeting an amylin meeting. The pitch is GLP-1-like results with dramatically better tolerability — and the early data is doing more than hinting at it.

A research-focused look at the two main classes of growth-hormone secretagogues — GHRH analogs and ghrelin mimetics — how they differ, and why scientists study them in combination.

A friendly, science-forward introduction to what peptides are, how they differ from proteins, the major research categories, and how they're studied — written for the curious newcomer.

A neutral, science-forward checklist for evaluating research-peptide suppliers — covering third-party testing, certificates of analysis, purity data, storage, reputation, and the legal "research use only" context.

A research-focused tour of 2026's most talked-about peptides, from the GLP-1/GIP/glucagon weight-loss wave to emerging longevity and cellular-repair compounds like MOTS-c and SS-31.

A look at the popular "Wolverine" stack — BPC-157 paired with TB-500 — and why these two peptides are so often discussed together in recovery research. Educational only; not medical or dosing advice.

BPC-157, the so-called "Body Protection Compound," is one of the most talked-about research peptides for tissue and gut healing. Here's what it is, how it's thought to work, and why it sparks so much curiosity.